Kyttaris, Vasileios C.Kampagianni, OuraniaTsokos, George2014-02-182013Kyttaris, Vasileios C., Ourania Kampagianni, and George C. Tsokos. 2013. “Treatment with Anti-Interleukin 23 Antibody Ameliorates Disease in Lupus-Prone Mice.” BioMed Research International 2013 (1): 861028. doi:10.1155/2013/861028. http://dx.doi.org/10.1155/2013/861028.2314-6133http://nrs.harvard.edu/urn-3:HUL.InstRepos:11717647Interleukin 23 receptor expressing IL-17 producing T cells have been shown to be important in the development of murine lupus. The usefulness of IL-23 inhibition in ameliorating lupus nephritis is unknown. We hypothesized that inhibition of IL-23 will ameliorate nephritis in lupus-prone mice. To this end, we treated MRL/lpr lupus-prone mice for 6 weeks with a rat anti-IL-23p19 antibody, which resulted in delaying the onset of nephritis without affecting the production of anti-dsDNA antibodies. The effect of the treatment was hampered by the production of murine anti-rat IgG antibodies. The amelioration of murine lupus by IL-23 inhibition strengthens the rationale for targeting IL-23 in patients with systemic lupus erythematosus.en-USJournal Article2014-02-1810.1155/2013/861028